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MVR was most frequently necessary for increasing MR or symptoms due
to mixed or multiple valve lesions (p < 0.001). Restenosis (loss of half the
initial gain in mitral area) accounted for only 15% of the indications for MVR.
Conclusion: Restenosis is an infrequent indication for MVR after BMV
Other factors including initially insufficient enlargement of the mitral orifice,
persistent symptoms, and progression of post-BMV MR are the major indi-
cations for MVR after balloon mitral valvotomy.
Ted Feldman, John D. Carroll, Howard C. Herrmann, Larry S. Dean, David
R. Holmes, Donald A. Rothbaum, Gerald Dorros, Igor F. Palacios, David
1. Kawanishi, Gregory S. Pavlides, N. American Inoue Investigation. University of
Chicago, Chicago, IL
The indications for mitral valve replacement (MVR) after balloon mitral valvo-
tomy (BMV) remain poorly characterized. Restenosis has been the focus of
most concerns regarding the long-term need for re-BMV or MVR. We re-
viewed the indications for MVR after BMV in 770 patients during 3 years.
MVR was necessary in 4.5% within 30 days of BMV The indication for
MVR was mitral regurgitation (MR) in 3.8% and failed BMV in 0.7%. Late
MVR (more than 30 days post BMV) was done in an additional 6.1 %.
in 62 179.5%) pts and regurgitation was present in 60 (76.9%). stenosis in 5
(6.4%) and both in 13 (16.7%). Five pts had undergone previous surgery for
aortic valve (3 repairs, 2 replacements). Associated mitral surgery was per-
formed in 22 (28.2%) pts. all of them undergoing repairs. The mean bypass
time for isolated Ross procedure was 117.9 ± 36.6 minutes (mins) 174-243
mins) and mean ischemic time 79.8 ± 25.1 mins (46-155 mins). The right
ventricular to pulmonary artery connection was established in all but one
case with homografts. There has been no hospital deaths or documented
thromboembolisms to date. There have been 2 (2.2%) late deaths, 1 unre-
lated and 1 due to systemic sepsis and renal shutdown in a pt with T-cell
abnormality and congenital immune deficiency at 12 and 36 months (mos).
respectively. Four pts (5%) have been reoperated: 1 for mitral valve repair fail-
ure and suture line leak with false aneurysm (6 mas) and 3 for autograft failure
with progressive regurgitation (20-26 mos). One reported valve showed his-
tology compatible with rheumatic valvulitis. Even though the left ventricular
dimensions and function show immediate recovery and are maintained in
the short follow-up, there is a small but definite progression of the autograft
regurgitation followed beyond 6 mos. The effect ofsizing: surgical distortion,
recurrence of rheumatic activity of these transplanted valves and of the re-
paired mitral valves remain to be evaluated in the long-term. In conclusion:
the Ross procedure, while being a safe and excellent option in the young,
growing pts with aortic valve disease, should be moderated by the concerns
expressed above.
Mitral Regurgitation (not Restenosis) is the Most
Frequent Indication for Valve Replacement After
Balloon Mitral Valvotomy
Cardiac Surgery Results in Changes of Atrial
Refractoriness that may Explain Vulnerability to
Postoperative Atrial Fibrillation
Duane P Pool, Harvey L. Leo, George Nadzam, Patrick J. Tchou, Patrick
M. McCarthy, Mina K. Chung. The Cleveland Clinic Foundation, Cleveland, OH
To test the hypothesis that vulnerability to atrial arrhythmias following car-
diac surgery may result from shortening of atrial wavelength (WL), the prod-
uct of conduction velocity ICV) and refractory period, electrophysiologic pa-
rameters were measured in 26 patients undergoing coronary artery bypass
grafting, using temporary atrial epicardial pacing electrodes placed intraop-
eratively. Atrial programmed stimulation was performed before and after car-
diopulmonary bypass (CPB) and daily when possible while electrodes were
intact. After CPB, effective and functional refractory periods (ERR FRP), mea-
sured from 2 atrial sites and at 2 paced cycle lengths (peL), paradoxically
prolonged. After CPB the 8 patients that subsequently developed postoper-
ative atrial fibrillation (AF) had even longer mean ERP (PCL 400, 230 ± 42
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Conclusions: Significant structural and functional V deterioration is com-
mon post MV repair for rheumatic MR. Presence of MCF at initial surgery
is associated with smaller V area and greater V gradient at follow-up as op-
posed to pure MR.
Regression of left ventricular hypertrophy (LVH) after valve replacement has
been studied extensively in the past; however, the time course of regres-
sion of coronary artery size has not yet been evaluated. Thus, cross-sectional
area (CSA) of the proximalleft( = anterior descending + circumflex) and right
coronary artery was determined by biplane quantitative coronary arteriogra-
phy in 10 controls (C) and 23 patients with LVH In = 15 with aortic and 8 with
mitral valve disease) before and 34 ± 28 months after valve replacement.
As an index of the appropriateness of CSA with respect to LV muscle mass
(LMM), CSAwas normalized by 100 g LMM. LMM was 69 ± 14g/m2 in C and
173 + 46 g/m2 in LVH (p < 0.01). Left coronary CSA was markedly increased
in LVH (28 ± 7 vs C = 14 ± 5 mm2; p < 0.01). whereas right coronary CSA
was only slightly (LVH: 12 ± 5 vs C = 8 ± 5 mm2, p < 0.05). Changes in CSA
and LMM early «18 months). intermediate (18--36 months). and late (>36
months after valve replacement were as follows:
Time Course of Regression of Coronary Artery
Size and Left Ventricular Hypertrophy After
Successful Valve Replacement
Giuseppe Vassalli, Bruno Villari, Philipp Kaufmann, Isabella Mayer, Marko Turina,
Otto M. Hess. Cardiology and Cardiovascular Surgery. University Hospital, Zurich,
Switzerland
Normalization of left coronary CSA by 100 g LMM was reduced at early
and indermediate (9 and 10 mm211 00 g, respectively; p < 0.05) but normal
at late follow-up (13 mm2/100 g) when compared to C (12 mm2/100 g). A
positive correlation (r = 0.57, p < 0.01) was found between follow-up and
CSMOO g.
Conclusions: Regression of coronary artery size occurs early after valve re-
placement suggesting a flow-mediated phenomenon. In contrast, LV muscle
mass decreases continuously over several years. Thus, the time course of
regression is different for vessels and muscle which might reflect different
regulatory mechanisms.
Zohair AI-Halees, Naresh Kumar, Begonia Gometza, Ricardo Gallo, Carlos
M.G. Duran. King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
Pulmonary autografts have shown promise in the intermediate and long-term
results as being an ideal valve substitute for diseased aortic valve. We have
adopted this procedure as an option for aortic valve replacement, especially
in the young, growing patients who are difficult to anticoagulate. In the pe-
riod between Jan 1990 and Aug 1994, we have performed this procedure on
79 patients (pts), 57 (72%) males and 22 128%) females. Their age ranged
from 1-41 years (yrs) (mean, 18.6 ± 7.36 yrs). The etiology was rheumatic
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